brobert
/
LogseqFMS
1
0
Fork 0
Code Issues Pull Requests Packages Projects Releases Wiki Activity
You cannot select more than 25 topics Topics must start with a letter or number, can include dashes ('-') and can be up to 35 characters long.
master
Branches Tags
${ item.name }
Create tag ${ searchTerm }
Create branch ${ searchTerm }
from '1c9eb4f42b'
${ noResults }
LogseqFMS/journals/2024_04_04.md

5.0 KiB
Raw Blame History

- # #Tareas - DONE PREPARAR presentación de María Santamaría SCHEDULED: <2024-04-04 Thu> - DONE [#A] PREPARAR presentación sobre las comunicaciones de STOP2030 para la reunión con el Advisory Board SCHEDULED: <2024-04-04 Thu> - DONE [#A] PREGUNTAR a Marina y Silvia si tienen claras algunas de las invitaciones que podríamos ir mandando ya para que yo vaya preparándolo SCHEDULED: <2024-04-04 Thu> - DONE ENTERARME de si hay reunión con Sonia y Dolores y Adela SCHEDULED: <2024-04-04 Thu> - TODO ACTUALIZAR lista de invitado al Evento con sugerencias de Marina SCHEDULED: <2024-04-04 Thu> - TODO ESCRIBIR a Chema Buceta para preguntarle qué tal van las gestiones con Caixaforum SCHEDULED: <2024-04-05 Fri> - TODO PEDIR Carteles para cribado de Chagas en el consulado el sábado 2024/05/04 a Scienseed SCHEDULED: <2024-04-05 Fri> DEADLINE: <2024-04-19 Fri> - TODO IR al cribado al consulado SCHEDULED: <2024-05-04 Sat> 
-

  • #Eventos

    • TODO 15:00 - 16:30: Reu equipo comunicaciones SCHEDULED: <2024-04-04 Thu 15:00> :AGENDA: estimated: 1h :END:
    • CANCELED 11:15 - 12:30: Presentación GEPI SCHEDULED: <2024-04-04 Thu>
    • CANCELED 13:00 - 14:00: Reunión Ade + Sonia + Dolores + Borja SCHEDULED: <2024-04-04 Thu 13:00>
    • TODO 16:00 - 17:00: STOP2030 - STAB Meeting SCHEDULED: <2024-04-04 Thu 16:00>

      • Notas

        • AK. To begin with ty to them. To be part of the STAB meeting and being availsable at the same time. I prepared a presentation which wont take more than 20-25 mins an get your input. We really value this. Adhoc afiliation with Liconsa. Affiliation to FMS. Estuvo en previous stop durante el ALIVE study.
        • John Amuasi: physician. Global health infectious diseases and global health department.
        • Raj Shankar Gosh: mefico trained in public health: working onf infectious Climate health and resistance and the founder at a startup in Dehli
        • Denise Mupfasoni: NTD department at WHO leading all the STH related activities. Key stakeholder on our. Geneva. Member as an observer in this group. Not a full member.
        • Pat Lamie: task force for global health. Colleague on AK durante unos 20 años.
        • Collins Okoyo: Kenya. Leader of WP3 on modelling and cost effectiveness.
        • Julie: Bridges, we lead wp5. Excited to hear.
        • Marina: Anthropologist. WP5 with bridges more focused on the comms.
        • Carla Valribiera: coordinating all the consortium members
        • AK: stop 1 y stop2 querían hacer un pivotal trial de la fdc y show safety and efficacy against STH
        • Liconsa responsability.
        • Liconsa tiene track record en gloabl health porque hacen el benznidazol y han prequalified ivermectin.
        • ISGlobal lidership de las biomedical sciences.
        • WP3 leaded by KEMRI: leaded by modelling and db but also as a siste.
        • wp4: the social sciences: acceptabiility feasibility and adherence: also clinical site, but also a leader through their expertise on other projects on acceptaibility.
        • WP5: policty, access, advocacy and communications.
        • Y por último Sanger working on developing surveillance methods por genomic ana
        • The target of the consorcios es crear goals and evidence needed by WHO in evaluating the incorporating this strategies into programs.
        • We know that the FDC también es util para oncho, lf, scabies y demás pero tenemos que elegir una disease of particular interest to perform the particular studies. So far the achievements have been: submission to EMA through art 58. the main target is leading the way to prequalification to WHO. We did the pivotal trial that demonstrated safety efficacy against T. Trichiura.
        • Our current main challenges are safety and acceptability. We've had conversations with the department in Geneva to align our strategies.
        • Evaluation of implementation strategies, pathways to programs and an access plan.
        • We look for your expertise in these 3 aspects. Our interest is go beyond the science limited to STH and a vision of global health and a program of implementation.
        • TODO LEER 2030 targets for soil-transmitted helminthiases de WHO SCHEDULED: <2024-04-21 Sun>
        • Of particular interest where the ocular nosequé
        • El clinical trial is under review. Nothing to highlight regarding safety, which lead us to go to test safety with bigger populations.
        • consideramos lo de 3 dosis para situaciones que no son las de MDA sino otros escenarios.
        • For strongi we didn't reach the recruitement size. The answer we wanted to provide we couldnt give.
        • Our project is proposing an innovation with our fdc but also for other ways of getting ivm.
        • Safety, palatability and

  • Cosas de gastos del Evento

    • Sala, catering, técnicos (Caixaforum)
    • Sala NH, comida NH
    • Chema Buceta
      • Se encarga de la relación con Caixaforum
      • Se encarga de la visita a Liconsa/Chemo/nosecual
    • Comida CA
    • Scienseed
      • Buscar cuántas horas han metido al evento
      • Me dio autorización (informal) Marina a decirles que si necesitan facturar algo por fuera lo hagan